Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
History, Companies, Art & Science
Explore the main themes, entities and connections around Ipsen. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment company rare medicine used patients beaufour group disease fondation henri drug united states diseases development france fda paris oncology
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ipsen | Founded | 1929 | 1.00 | infobox |
| Ipsen | Founder | Henri Beaufour | 1.00 | infobox |
| Ipsen | Headquarters | Balard, Paris 15, France | 1.00 | infobox |
| Ipsen | Industry | Pharmaceutical | 1.00 | infobox |
| Ipsen | ISIN | FR0010259150 | 1.00 | infobox |
| Ipsen | Key people | Marc de Garidel (Non-executive Chairman) David Loew (Chief Executive Officer) | 1.00 | infobox |
| Ipsen | Net income | €347million(2024) | 1.00 | infobox |
| Ipsen | Number of employees | 5,300 | 1.00 | infobox |
| Ipsen | Operating income | €1.109 billion(2024) | 1.00 | infobox |
| Ipsen | Products | List of medicines | 1.00 | infobox |
| Ipsen | Revenue | €3.401 billion(2024) | 1.00 | infobox |
| Ipsen | Traded as | Euronext Paris: IPN CAC Mid 60 Component | 1.00 | infobox |
| Ipsen | Type | Public | 1.00 | infobox |
| Ipsen | Website | www.ipsen.com | 1.00 | infobox |
| Ipsen | is a | French biopharmaceutical company headquartered in Paris | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.